SEC Tracker
Get the app

Abeona Therapeutics ABEO

Abeona Therapeutics: Ownership stake disclosure

Ownership stake disclosure

Form
Schedule 13D
Filed
Importance
Notable
  1. Reporting Persons include James Russell Revocable Trust and James Russell.
  2. Acquired 3,479,963 shares, 6.1% of outstanding shares.
  3. Purchased shares with personal funds totaling $17,776,513.
  4. Expressed concerns about company governance and management.

Written from the Schedule 13D on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Abeona Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Tonix Pharmaceuticals Holding TNXP public float $271M, Jun 30, 2025
  2. Vanda Pharmaceuticals VNDA public float $269M, Jun 30, 2025
  3. Ocugen OCGN public float $279M, Jun 30, 2025
  4. Mersana Therapeutics MRSN
  5. Atea Pharmaceuticals AVIR public float $263M, Jun 30, 2025